Elsevier

Seminars in Hematology

Volume 37, Issue 2, April 2000, Pages 122-129
Seminars in Hematology

The duffy protein: A malarial and chemokine receptor

https://doi.org/10.1016/S0037-1963(00)90037-4Get rights and content

Abstract

A major advance towards understanding the Duffy blood group system has been achieved with the cloning of FY, a single-copy gene located in the 1q22→q23 region of chromosome 1. The product of FY is an acidic glycoprotein (gp-Fy), which spans the plasma membrane seven times and has an exocellular N-terminal domain and an endocellular C-terminal domain. The system consists of four alleles, five phenotypes, and five antigens. FYA, FYB, FYBES, and FYBWK are the alleles; Fy(a + b −), Fy(a − b +), Fy(a + b +), Fy(a − b + wK), and Fy(a − b −), are the phenotypes, and Fya, Fyb, Fy3, Fy5, and Fy6 are the antigens. Fy(a − b −), or Duffy-negative individuals, lack the Duffy protein on erythrocytes and are predominantly African and American blacks. They have the FYBES allele with a mutation in the promoter region, which abolishes the expression of the protein in erythrocytes only. In the few cases of non-black Fy(a − b −) individuals, a nonsense mutation prevents the synthesis of gp-Fy. In Fy(a − b + wK) erythrocytes, the Fyb antigen is weakly expressed due to a reduced amount of the protein. The Fy5 antigen includes the Rh protein, and the Fy6 antigen is defined by a murine monoclonal antibody. Gp-Fy is produced in several cell types, including endothelial cells of capillary and postcapillary venules, epithelial cells of kidney collecting ducts, and lung alveoli, as well as Purkinje cells of the cerebellum. The Duffy protein plays a role in inflammation and in malaria infection. The protein is a member of the superfamily of chemokine receptors and is the receptor to which certain malarial parasites bind to invade red blood cells. The parasite-specific binding site, the binding site of chemokines, and the major antigenic domains are located in overlapping regions at the exocellular N terminus of the Duffy protein.

References (52)

  • MJ Ruiz-Echevarria et al.

    Making sense of nonsense in yeast

    TIBS

    (1996)
  • C Tournamille et al.

    Close association of the first and fourth extracellular domains of the Duffy antigen/receptor for chemokines by a disulfide bond is required for ligand binding

    J Biol Chem

    (1997)
  • C Tournamille et al.

    Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fyx individuals

    Blood

    (1998)
  • A Varshavsky

    The N-terminal rule

    Cell

    (1992)
  • K Wasniowska et al.

    Identification of the Fy6 epitope recognized by two monoclonal antibodies in the N-terminal extracellular portion of the Duffy antigen receptor for chemokines

    Mol Immunol

    (1996)
  • L Zhao-hai et al.

    The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino terminal domain

    J Biol Chem

    (1995)
  • JA Albrey et al.

    A new antibody, anti-Fy3, in the Duffy blood group system

    Vox Sang

    (1971)
  • JF Bazan

    Structural design and molecular evolution of a cytokine receptor superfamily

  • KM Beattie

    The Duffy Blood Group System

  • O Behzad et al.

    A new anti-erythrocyte antibody in the Duffy system: Anti-Fy4

    Vox Sang

    (1973)
  • C Bloy et al.

    Human monoclonal antibody against Rh(D) antigen: Partial characterization of the Rh(D) polypeptide from human erythrocytes

    Blood

    (1987)
  • DI Buchanan et al.

    An Alberta Cree Indian with a rare Duffy antibody, anti-Fy 3

    Vox Sang

    (1976)
  • A Chaudhuri et al.

    Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite

  • CE Chitnis et al.

    The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasite to erythrocytes

    J Exp Med

    (1996)
  • B Chown et al.

    The Duffy blood group system in Caucasians: Evidence for a new allele

    Am J Hum Genet

    (1965)
  • KI Colledge et al.

    Anti-Fy5 an antibody disclosing a probable association between the Rhesus and Duffy blood group genes

    Vox Sang

    (1973)
  • Cited by (92)

    • Blood Group Serotyping and Genotyping

      2022, Encyclopedia of Infection and Immunity
    • Duffy blood group system and ocular toxoplasmosis

      2020, Infection, Genetics and Evolution
      Citation Excerpt :

      However, our data do not support this proposition. The arguments of Chaves Jorge et al. (2003)(Chaves Jorge et al., 2003) are supported by the demonstrations that Duffy blood group antigens have important role in the invasion of human erythrocytes by Plasmodium vivax (Kaur et al., 2019; King et al., 2011; Pogo and Chaudhuri, 2000) and Babesia divergens (La Hoz and Morris, 2019; Nakamoto et al., 1998; Sevilla et al., 2018; Suarez et al., 2019). Further studies with large numbers of patients from different populations would be required to validate this association since the frequencies of the Duffy phenotypes vary considerably between the ethnicities.

    • Alloimmunization in Pregnancy

      2020, Immunologic Concepts in Transfusion Medicine
    • Duffy blood group system – the frequency of Duffy antigen polymorphisms and novel mutations in the Polish population

      2019, Transfusion and Apheresis Science
      Citation Excerpt :

      The Duffy-negative phenotype Fy(a−b−), frequent in Africans, but very rare in Caucasians, is defined by the homozygous state of FY*02N.01alleles, associated with a SNP c.-67T > C in the promoter region of the FY gene, which suppresses erythroid expression of this gene without affecting its expression in other tissues [1,2]. The GATA-1 mutation c.-67T > C has been previously reported as -33 and -46 [6–8]. The same mutation has been identified in the promoter region of FY*A allele but it is very rare [9,10].

    View all citing articles on Scopus

    Supported by Specialized Center of Research (SCOR) Grant No. 54453 to A.O.P.

    View full text